Evidence suggests that the Zika virus has been circulating in West Africa for two decades.
Researchers identified an enhancement of Zika virus growth in cell cultures by using blood samples from people infected with dengue and West Nile virus.
The DNA vaccine uses genes from the virus to create an immune response.
The National Environment Agency (NEA) reports that both cases are from the same household.
The ‘Hi-C’ technique will make assembling all an organism’s genetic material from scratch easier and cheaper.
Researchers have programmed RNA nanoparticles that could protect against the Zika virus.
Research shows that screening methods that detect Zika virus genetic material can be used to ensure Zika free blood supplies.
Scientists have assembled the genomes of the A. aegypti and Culex quinquefasciatus mosquitoes.
The patient had “multiple exposures” to areas where mosquitoes were spreading the virus.
IBM is assisting Taiwan and Panama in fighting dengue fever and Zika. This assistance comes as part of IBM's pro bono Health Corps initiative.